These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16919636)

  • 1. Paradoxical increase in LDL oxidation by endothelial cells from an atherosclerosis-resistant mouse strain.
    Miyoshi T; Matsumoto AH; Shi W
    Atherosclerosis; 2007 Jun; 192(2):259-65. PubMed ID: 16919636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase.
    Shi W; Wang X; Shih DM; Laubach VE; Navab M; Lusis AJ
    Circulation; 2002 Apr; 105(17):2078-82. PubMed ID: 11980688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility.
    Miyoshi T; Tian J; Matsumoto AH; Shi W
    Atherosclerosis; 2006 Nov; 189(1):99-105. PubMed ID: 16405896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis.
    Miller YI; Choi SH; Fang L; Tsimikas S
    Subcell Biochem; 2010; 51():229-51. PubMed ID: 20213546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Effects on oxidation of low density lipoproteins.
    Kälvegren H; Bylin H; Leanderson P; Richter A; Grenegård M; Bengtsson T
    Thromb Haemost; 2005 Aug; 94(2):327-35. PubMed ID: 16113822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridoxine prevents dysfunction of endothelial cell nitric oxide production in response to low-density lipoprotein.
    Ji Y; Diao J; Han Y; Huang Y; Bai H; Chen Q; Fan L; Ferro A
    Atherosclerosis; 2006 Sep; 188(1):84-94. PubMed ID: 16300769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway.
    Scheidegger KJ; Butler S; Witztum JL
    J Biol Chem; 1997 Aug; 272(34):21609-15. PubMed ID: 9261183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis.
    Li C; Chen JW; Liu ZH; Shen Y; Ding FH; Gu G; Liu J; Qiu JP; Gao J; Zhang RY; Shen WF; Wang XQ; Lu L
    Atherosclerosis; 2018 Nov; 278():197-209. PubMed ID: 30300788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine enhances nitrative stress and exacerbates tumor necrosis factor-alpha toxicity to human endothelial cells in culture: prevention by propofol.
    Xia Z; Luo T; Liu HM; Wang F; Xia ZY; Irwin MG; Vanhoutte PM
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):358-67. PubMed ID: 20125033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase.
    Yoshida H; Sasaki K; Namiki Y; Sato N; Tada N
    Atherosclerosis; 2005 Mar; 179(1):97-102. PubMed ID: 15721014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone up-regulates 12- and 15-lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells.
    Limor R; Kaplan M; Sharon O; Knoll E; Naidich M; Weisinger G; Keidar S; Stern N
    J Cell Biochem; 2009 Dec; 108(5):1203-10. PubMed ID: 19795383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low density lipoprotein receptor-related protein is required for macrophage-mediated oxidation of low density lipoprotein by 12/15-lipoxygenase.
    Xu W; Takahashi Y; Sakashita T; Iwasaki T; Hattori H; Yoshimoto T
    J Biol Chem; 2001 Sep; 276(39):36454-9. PubMed ID: 11479307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway.
    McNally AK; Chisolm GM; Morel DW; Cathcart MK
    J Immunol; 1990 Jul; 145(1):254-9. PubMed ID: 2162888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR; Moulton KS; Kazlauskas A
    Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density lipoprotein receptor-related protein-mediated membrane translocation of 12/15-lipoxygenase is required for oxidation of low density lipoprotein by macrophages.
    Zhu H; Takahashi Y; Xu W; Kawajiri H; Murakami T; Yamamoto M; Iseki S; Iwasaki T; Hattori H; Yoshimoto T
    J Biol Chem; 2003 Apr; 278(15):13350-5. PubMed ID: 12566436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lipoxygenase-isoforms in atherogenesis.
    Kühn H; Römisch I; Belkner J
    Mol Nutr Food Res; 2005 Nov; 49(11):1014-29. PubMed ID: 16270276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
    Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine.
    Rahman MM; Varghese Z; Fuller BJ; Moorhead JF
    Clin Nephrol; 1999 Feb; 51(2):98-107. PubMed ID: 10069645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.